Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 106

Similar articles for PubMed (Select 21569348)

1.

Interaction of a traditional Chinese Medicine (PHY906) and CPT-11 on the inflammatory process in the tumor microenvironment.

Wang E, Bussom S, Chen J, Quinn C, Bedognetti D, Lam W, Guan F, Jiang Z, Mark Y, Zhao Y, Stroncek DF, White J, Marincola FM, Cheng YC.

BMC Med Genomics. 2011 May 11;4:38. doi: 10.1186/1755-8794-4-38.

2.

PHY906(KD018), an adjuvant based on a 1800-year-old Chinese medicine, enhanced the anti-tumor activity of Sorafenib by changing the tumor microenvironment.

Lam W, Jiang Z, Guan F, Huang X, Hu R, Wang J, Bussom S, Liu SH, Zhao H, Yen Y, Cheng YC.

Sci Rep. 2015 Mar 30;5:9384. doi: 10.1038/srep09384.

3.

The advantages of using traditional Chinese medicine as an adjunctive therapy in the whole course of cancer treatment instead of only terminal stage of cancer.

Qi F, Zhao L, Zhou A, Zhang B, Li A, Wang Z, Han J.

Biosci Trends. 2015 Feb;9(1):16-34. doi: 10.5582/bst.2015.01019.

4.
5.

Research advances on TCM anti-tumor effects and the molecular mechanisms.

Qiu X, Jia J.

J Cancer Res Ther. 2014 Aug;10 Suppl 1:8-13. doi: 10.4103/0973-1482.139744. Review.

6.

Role of traditional Chinese medicine and its chemical components in anti-tumor metastasis.

Li F, Zhang W.

J Cancer Res Ther. 2014 Aug;10 Suppl 1:20-6. doi: 10.4103/0973-1482.139748. Review.

7.

Three advantages of using traditional Chinese medicine to prevent and treat tumor.

Ling CQ, Yue XQ, Ling C.

J Integr Med. 2014 Jul;12(4):331-5. doi: 10.1016/S2095-4964(14)60038-8. Review.

PMID:
25074882
8.

Antitumor Effects and Biological Mechanism of Action of the Aqueous Extract of the Camptotheca acuminata Fruit in Human Endometrial Carcinoma Cells.

Lin CS, Chen PC, Wang CK, Wang CW, Chang YJ, Tai CJ, Tai CJ.

Evid Based Complement Alternat Med. 2014;2014:564810. doi: 10.1155/2014/564810. Epub 2014 May 21.

9.
10.

CPT changes in 2003: an overview.

Preskitt JT, Harris JA, Dworakowski I.

Bull Am Coll Surg. 2003 Feb;88(2):16-20. No abstract available.

PMID:
23581038
11.

Synergism and rules from combination of Baicalin, Jasminoidin and Desoxycholic acid in refined Qing Kai Ling for treat ischemic stroke mice model.

Li J, Wu RG, Meng FY, Wang Z, Wang CM, Wang YY, Zhang ZJ.

PLoS One. 2012;7(9):e45811. doi: 10.1371/journal.pone.0045811. Epub 2012 Sep 26.

12.

TanshinoneIIA ameliorates inflammatory microenvironment of colon cancer cells via repression of microRNA-155.

Tu J, Xing Y, Guo Y, Tang F, Guo L, Xi T.

Int Immunopharmacol. 2012 Dec;14(4):353-61. doi: 10.1016/j.intimp.2012.08.015. Epub 2012 Sep 13.

PMID:
22982040
13.

The synergistic effects of low-dose irinotecan and TRAIL on TRAIL-resistant HT-29 colon carcinoma in vitro and in vivo.

Zhu H, Zhao F, Yu S, He J, Deng L, Yi C, Huang Y.

Int J Mol Med. 2012 Nov;30(5):1087-94. doi: 10.3892/ijmm.2012.1105. Epub 2012 Aug 21.

PMID:
22922573
14.

Enhanced chemosensitivity to CPT-11 in colorectal carcinoma xenografts by small hairpin RNA interference targeting PLK1.

Fan P, Zhang S, Tian H, Yan N, Dai L, Zhang X, Cheng L, Li C, Li Y, Chen X, Shi G, Yang Y, Wei Y, Deng H.

Neoplasma. 2012;59(6):676-84. doi: 10.4149/neo_2012_086.

PMID:
22862168
15.

Preclinical studies of the Chinese Herbal Medicine formulation PHY906 (KD018) as a potential adjunct to radiation therapy.

Rockwell S, Grove TA, Liu Y, Cheng YC, Higgins SA, Booth CJ.

Int J Radiat Biol. 2013 Jan;89(1):16-25. doi: 10.3109/09553002.2012.717733. Epub 2012 Sep 3.

16.

Traditional Chinese medicine and immune regulation.

Ma HD, Deng YR, Tian Z, Lian ZX.

Clin Rev Allergy Immunol. 2013 Jun;44(3):229-41. doi: 10.1007/s12016-012-8332-0. Review.

PMID:
22826112
18.

Injectable poly(organophosphazene)-camptothecin conjugate hydrogels: synthesis, characterization, and antitumor activities.

Cho JK, Chun C, Kuh HJ, Song SC.

Eur J Pharm Biopharm. 2012 Aug;81(3):582-90. doi: 10.1016/j.ejpb.2012.04.008. Epub 2012 Apr 24.

PMID:
22554767
19.

Ethanol extract from a Chinese herbal formula, "Zuojin Pill", inhibit the expression of inflammatory mediators in lipopolysaccharide-stimulated RAW 264.7 mouse macrophages.

Wang QS, Cui YL, Dong TJ, Zhang XF, Lin KM.

J Ethnopharmacol. 2012 May 7;141(1):377-85. doi: 10.1016/j.jep.2012.02.049. Epub 2012 Mar 6.

PMID:
22414473
20.

Pharmacokinetics and antitumor efficacy of XMT-1001, a novel, polymeric topoisomerase I inhibitor, in mice bearing HT-29 human colon carcinoma xenografts.

Walsh MD, Hanna SK, Sen J, Rawal S, Cabral CB, Yurkovetskiy AV, Fram RJ, Lowinger TB, Zamboni WC.

Clin Cancer Res. 2012 May 1;18(9):2591-602. doi: 10.1158/1078-0432.CCR-11-1554. Epub 2012 Mar 5.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk